Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)
Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 70518-4557
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-4557). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)
This text presents data on the reduction in CPS (Complex Partial Seizure) rate for patients taking Divalproex Sodium Delayed-Release Tablets compared to the placebo. The diagram shows the percentage of patients who experienced improvement, no change, or worsening in their condition.*
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)
This is a table showing the percentage reduction in CPS rate for different doses of Divalproex Sodium Delayed-Release Tablets. It includes 100%, 75%, 50%, and 25% reduction rates, as well as a category for no change in CPS rate. Different dosages and percentages are mentioned for high dose and low dose variations of the tablets, with the percentage of patients likely also considered.*
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)
This is a list of numerical values and medication information. The document contains numbers, including 12, 04, 0.2, 0.6, and some additional information related to a placebo and divalproex sodium extended-release tablets. The text also mentions a p-value of 0.006.*
Remedy_label (Remedy Label)
This text provides important information about Divalproex Sodium tablets manufactured by Unichem Labs Ltd., Goa, India. The tablets are extended-release with a strength of 250 mg and come in a quantity of 30 tablets. It includes storage instructions to keep the medication at 20-25°C and precautions about keeping it out of reach of children. The tablets are repackaged by RemedyRepack and are for prescription use only. The manufacturer's NDC number is 29300-0380-05 and the product has a LOT number, but the expiry date is not specified.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
